Reprint

Antimicrobial and Anti-infective Activity of Natural Products

Edited by
September 2023
348 pages
  • ISBN978-3-0365-8725-7 (Hardback)
  • ISBN978-3-0365-8724-0 (PDF)

This book is a reprint of the Special Issue Antimicrobial and Anti-infective Activity of Natural Products that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This reprint, organized with the recent publications of the Special Issue Antimicrobial and Anti-infective Activity of Natural Products in the journal Antibiotics, is a collection of the recent advances in the discovery of new antimicrobial compounds from natural products, mechanisms of action of pure compounds, in silico evidence of antimicrobial activity, synergistic associations with antibiotics, compounds with antiviral activity or capable of neutralizing bacterial resistance to antibiotics, as well as in vivo studies to demonstrate the effectiveness of compounds.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
Punica granatum; galloyl-HHDP-glucose; in silico analysis; in vitro analysis; candidiasis; sepsis; inflammation; Escherichia coli; cinnamaldehyde; Bixa orellana; bioprospecting; in silico; Tenebrio molitor; anti-mycobacteria activity; anti-inflammatory activity; protocatechuic acid ethyl ester; erythromycin; fractional inhibitory concentration; Staphylococcus spp.; sodium bituminosulfonate; Staphylococcus aureus; bactericidal activity; biotechnology; marine actinobacteria; antibacterial activity; anti-biofilm activity; quorum-quenching activity; natural compounds; extracts; biosynthetic gene clusters (BGCs); acne vulgaris; Cutibacterium acnes; Staphylococcus aureus; Staphylococcus epidermidis; surface-active compounds; biosurfactants; bioemulsifier; biological properties; biotechnology; Toxoplasma gondii; Paraboeremia selaginellae; endophytic fungi; natural products; bioactivity; biphenyl ether; bioxanthracene; phomalactone; antibacterial activity; bacterial resistance; sapogenin; MDR pathogens; silver nanoparticles; antibacterial activity; Mangifera indica leaf extract; Triticum spp.; marine Actinomycetes; Beijerinickia fluminensis; antibacterial activity; FTIR; GC-MS; pneumonia; volatile oils; Boswellia; MIC; MBC; Malvaviscus arboreus; GC-MS; HPLC; antimicrobial; antioxidant; HepG2; Microsporum canis; Coleus amboinicus; essential oil; ethanolic extracts; antifungal; biofilm formation; Vismia guianensis; Candida albicans; vismione D; Candida glabrata; CaCYP51; antifungals; lacre; antibiotic resistance; alkaloids; multidrug-resistant; MRSA; organosulfur compounds; phenolic compounds; phytochemicals; plant-based extracts; Pseudomonas aeruginosa; Staphylococcus aureus; sulforaphane; antifungal activity; Candida albicans; in silico analysis; Aspergillus fumigatus; OSMAC; metabolomics; molecular docking; antitrypanosomal; antiplasmodial; in silico molecular docking; venom; antimicrobial activity; fraction; bee; protein; n/a